These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38423236)

  • 1. Colchicine and plaque: A focus on atherosclerosis imaging.
    Aldana-Bitar J; Golub IS; Moore J; Krishnan S; Verghese D; Manubolu VS; Benzing T; Ichikawa K; Hamal S; Kianoush S; Anderson LR; Ramirez NR; Leipsic JA; Karlsberg RP; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():68-75. PubMed ID: 38423236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Colchicine in Atherosclerotic Cardiovascular Disease.
    Kurup R; Galougahi KK; Figtree G; Misra A; Patel S
    Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE; Shin S; deKemp RA; Dowlatshahi D; Tavoosi A; Wiefels C; Liu P; Lochnan H; MacPherson PA; Chong AY; Torres C; Leung E; Tawakol A; Ahmadi A; Garrard L; Lefebvre C; Kelly C; MacPhee P; Tilokee E; Raggi P; Wells GA; Beanlands R
    BMJ Open; 2023 Nov; 13(11):e074463. PubMed ID: 37949621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Colchicine in Coronary Artery Disease.
    Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN
    Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation.
    Schwarz N; Fernando S; Chen YC; Salagaras T; Rao SR; Liyanage S; Williamson AE; Toledo-Flores D; Dimasi C; Sargeant TJ; Manavis J; Eddy E; Kanellakis P; Thompson PL; Tan JTM; Snel MF; Bursill CA; Nicholls SJ; Peter K; Psaltis PJ
    FASEB J; 2023 Apr; 37(4):e22846. PubMed ID: 36856983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine's Role in Cardiovascular Disease Management.
    Buckley LF; Libby P
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1031-1041. PubMed ID: 38511324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine in atherosclerotic cardiovascular disease.
    Tucker B; Goonetilleke N; Patel S; Keech A
    Heart; 2024 Apr; 110(9):618-625. PubMed ID: 38331560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of colchicine on patients with acute and chronic coronary artery disease.
    Madanchi M; Young M; Tersalvi G; Maria Cioffi G; Attinger-Toller A; Cuculi F; Kurmann R; Bossard M
    Eur J Intern Med; 2024 Jul; 125():1-9. PubMed ID: 38238134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine in ischemic heart disease: the good, the bad and the ugly.
    D'Amario D; Cappetta D; Cappannoli L; Princi G; Migliaro S; Diana G; Chouchane K; Borovac JA; Restivo A; Arcudi A; De Angelis A; Vergallo R; Montone RA; Galli M; Liuzzo G; Crea F
    Clin Res Cardiol; 2021 Oct; 110(10):1531-1542. PubMed ID: 33713178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Yong J; Tian J; Jiang W; Zhao X; Zhang H; Song X
    Clin Ther; 2022 Aug; 44(8):1150-1159. PubMed ID: 35907660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.
    Zhu Y; Fang Y; Wang Y; Han D; Liu J; Tian L; Xu M; Wang Y; Cao F
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1530-1543. PubMed ID: 38372216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Impact of Colchicine on Coronary Plaque Phenotype After Myocardial Infarction with Optical Coherence Tomography: Rationale and Design of the COCOMO-ACS Study.
    Montarello NJ; Singh K; Sinhal A; Wong DTL; Alcock R; Rajendran S; Dautov R; Barlis P; Patel S; Nidorf SM; Thompson PL; Salagaras T; Butters J; Nerlekar N; Di Giovanni G; Ottaway JL; Nicholls SJ; Psaltis PJ
    Cardiovasc Drugs Ther; 2022 Dec; 36(6):1175-1186. PubMed ID: 34432196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation.
    Meyer-Lindemann U; Mauersberger C; Schmidt AC; Moggio A; Hinterdobler J; Li X; Khangholi D; Hettwer J; Gräßer C; Dutsch A; Schunkert H; Kessler T; Sager HB
    Front Immunol; 2022; 13():898690. PubMed ID: 35860249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
    Demidowich AP; Levine JA; Apps R; Cheung FK; Chen J; Fantoni G; ; Patel TP; Yanovski JA
    Int J Obes (Lond); 2020 Aug; 44(8):1793-1799. PubMed ID: 32461554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine in Cardiovascular Disease: In-Depth Review.
    Deftereos SG; Beerkens FJ; Shah B; Giannopoulos G; Vrachatis DA; Giotaki SG; Siasos G; Nicolas J; Arnott C; Patel S; Parsons M; Tardif JC; Kovacic JC; Dangas GD
    Circulation; 2022 Jan; 145(1):61-78. PubMed ID: 34965168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview.
    Nidorf SM; Thompson PL
    Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.